PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes.

Saved in:
Bibliographic Details
Title: PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes.
Authors: Qin, Ya-Zhen (AUTHOR), Zhu, Hong-Hu (AUTHOR), Liu, Yan-Rong1 (AUTHOR), Wang, Ya-Zhe1 (AUTHOR), Shi, Hong-Xia1 (AUTHOR), Lai, Yue-Yun1 (AUTHOR), Xu, Lan-Ping1 (AUTHOR), Liu, Dai-Hong1 (AUTHOR), Jiang, Qian1 (AUTHOR), Li, Ling-Di1 (AUTHOR), Jiang, Bin1 (AUTHOR), Liu, Kai-Yan1 (AUTHOR), Huang, Xiao-Jun1 (AUTHOR) huangxiaojun@bjmu.edu.cn
Source: Leukemia & Lymphoma. Jul2013, Vol. 54 Issue 7, p1442-1449. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.3109/10428194.2012.743656